A nonsynonymous SNP in human cytosolic sialidase in a small Asian population results in reduced enzyme activity: potential link with severe adverse reactions to oseltamivir-Reference-Cited by-全球学者库

A nonsynonymous SNP in human cytosolic sialidase in a small Asian population results in reduced enzyme activity: potential link with severe adverse reactions to oseltamivir

Published:2007-04 Issue:4 Volume:17 Page:357-362
ISSN:1001-0602
Container-title:Cell Research
language:en
Short-container-title:Cell Res

Author:

Li Chuan-Yun,Yu Quan,Ye Zhi-Qiang,Sun Ying,He Quanyuan,Li Xiao-Mo,Zhang Wuxue,Luo Jingchu,Gu Xiaocheng,Zheng Xiaofeng,Wei Liping

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/cr200727.pdf

Reference28 articles.

1. Varghese JN, Laver WG, Colman PM . Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution. Nature 1983; 5912:35–40.

2. Bossart-Whitaker P, Carson M, Babu YS, Smith CD, Laver WG, Air GM . Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid. J Mol Biol 1993; 232:1069–1083.

3. Burmeister WP, Ruigrok RW, Cusack S . The 2.2 Å resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. EMBO J 1992; 11:49–56.

4. Janakiraman MN, White CL, Laver WG, Air GM, Luo M . Structure of influenza virus neuraminidase B/Lee/40 complexed with sialic acid and a dehydro analog at 1.8-Å resolution: implications for the catalytic mechanism. Biochemistry 1994; 33:8172–8179.

5. Garman E, Laver G . Controlling influenza by inhibiting the virus's neuraminidase. Curr Drug Targets 2004; 5:119–136.

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic susceptibility in pneumoconiosis in China: a systematic review;International Archives of Occupational and Environmental Health;2022-07-29

2. In-silico profiling of SLC6A19, for identification of deleterious ns-SNPs to enhance the Hartnup disease diagnosis;Computational Toxicology;2022-05

3. Severe Congenital Thrombocytopenia Characterized by Decreased Platelet Sialylation and Moderate Complement Activation Caused by Novel Compound Heterozygous Variants in GNE;Frontiers in Immunology;2021-11-09

4. Docking Techniques in Toxicology: An Overview;Current Bioinformatics;2020-11-11

5. Assessment of adverse events related to anti-influenza neuraminidase inhibitors using the FDA adverse event reporting system and online patient reviews;Scientific Reports;2020-02-20